Millennium Management
TIL icon

Millennium Management’s Instil Bio TIL Stock Holding History

Millennium Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,885
Closed -$24.7K – 6529
2023
Q3 		$24.7K Buy
+2,885
New +$29.1K ﹤0.01% 5604

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's TIL Position: Q1 2026 in Review

Millennium Management reduced its Instil Bio (TIL) stake by 45% in Q1 2026, selling an estimated $891K and leaving 132,946 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4318.

Millennium Management first reported a position in TIL in Q1 2021 and has held it in 14 quarters since. The position peaked at $8.72M in Q1 2021. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Millennium Management held 132,946 shares of Instil Bio worth $1.1M as of Q1 2026.
  • Millennium Management sold 109,826 Instil Bio shares in Q1 2026, an estimated $891K.
  • Instil Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4318 holding.
  • Millennium Management first reported a position in Instil Bio in Q1 2021 and has held it in 14 quarters since.
  • Millennium Management's Instil Bio position peaked at $8.72M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.